[Registry] Liquid vs Tissue Biopsy Concordance in Samples of 1st Suspected Breast Cancer Recurrence & Metastasis
Condition: Breast Cancer
Sponsor: Epic Sciences
Protocol PCS-001: Liquid vs Tissue Biopsy Concordance in Samples of 1st Suspected BCa Recurrence/Metastasis and Evaluation of DefineMBC Comprehensive Cancer Profiling Liquid Biopsy LDT
Breast cancer patients with recurrent or de novo metastatic disease outside of the breast/axilla/supraclavicular regions that have not yet been treated with first line metastatic therapy.
The purpose of this study is to test an ideated product concept with an intended use as a blood-based testing alternative for patients with symptoms of recurrent metastatic breast cancer when surgical tissue biopsy is infeasible or invasive biopsy is medically contraindicated. The intended use is to aid in the diagnosis of suspected breast cancer recurrence & provide standard of care Hormone Receptor (HR)/HER2 status, which inform immediate treatment decisions.
For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.